Vote Scores

Home / Companies / Verona Pharma Plc / 24 Apr 2025

Meeting · year to 30 June 2025254 filers reporting

Verona Pharma Plc: meeting of 24 Apr 2025

Votes reported on Form N-PX, item by item

254 Form N-PX filers reported votes at the Verona Pharma Plc meeting of 24 Apr 2025. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 96.7% of reported votes for; 6 filers withheld from or voted against at least one nominee.

303 vote records from 74 filers. 1 of the 74 filers that marked the item either way voted against management.

98.6% for1.4% against1.4% against management74 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

358 vote records from 253 filers. 160 of the 239 filers that marked the item either way voted against management. 14 filers reported this item without a management mark.

30.4% for63.6% against5.9% other66.9% against management253 filers59.1% for40.9% against0.0% other40.9% against management62,292,159 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

201 vote records from 74 filers. 0 of the 74 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management74 filers100.0% for0.0% against0.0% against management25,650,104 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

202 vote records from 74 filers. 0 of the 74 filers that marked the item either way voted against management.

97.3% for0.0% against2.7% other0.0% against management74 filers100.0% for0.0% against0.0% against management25,651,856 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

103 vote records from 76 filers. 57 of the 76 filers that marked the item either way voted against management.

23.7% for75.0% against1.3% other75.0% against management76 filers52.1% for47.8% against0.1% other47.8% against management12,264,765 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

88 vote records from 66 filers. 0 of the 66 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management66 filers100.0% for0.0% against0.0% against management12,594,808 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

13 vote records from 8 filers. 0 of the 8 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management8 filers100.0% for0.0% against0.0% against management231,120 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForAgainst *For
BlackRock and iSharesForAgainst *For
FidelityForAgainst *For
American CenturyForAgainst *For
Franklin TempletonForAgainst *For
InvescoNo reportForNo report
EquitableForAgainst *For
Nuveen and TIAANo reportForNo report
ProShares and ProFundsForAgainst *For
John Hancock and ManulifeForAgainst *For
Morgan Stanley, Eaton Vance and CalvertNo reportAgainst *No report
Goldman SachsForForFor
PGIM and PrudentialForAgainst *For
Northern Trust and FlexSharesNo reportForNo report
SEINo reportAgainst *No report
T. Rowe PriceForAgainst *For
First TrustForAgainst *For
Russell InvestmentsForAgainst *For
NationwideForAgainst *For
Victory CapitalForAgainst *For
Brighthouse FundsForAgainst *For
Columbia ThreadneedleForForFor
BNY MellonNo reportForNo report
PrincipalForAgainst *For
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
Hartford FundsForAgainst *For
AllspringForAgainst *For
MassMutualForAgainst *For
Janus HendersonForForFor
Neuberger BermanForAgainst *For
Natixis and Loomis SaylesForAgainst *For
Lord AbbettForForFor
Artisan PartnersForAgainst *For

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Verona Pharma Plc meeting?

254 Form N-PX filers reported votes at the meeting of 24 Apr 2025. On say-on-pay, 160 of 239 voted against management (66.9%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Verona Pharma Plc on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Verona Pharma Plc

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Verona Pharma Plc with a meeting date within three days of 24 Apr 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.